[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fx1c2sxcX2Bbu6PA8mrsKGeGHF8-SZo6HzMb1WI9SNJE":8,"$fsTuzOSYXIVEpEsvxpUG_S1m0FThaC165qx_KGiXxs7c":55,"$fj-qqIvSxQZDyzofSJHjDuL1T8lEo6hE4HdXCvUG_c0A":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65552,867153,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","庞杰铖","嵊州市人民医院","肝胆外科","住院医师",210,0,"胰腺癌中期化疗药品安全用药实用指南","","https://ystcdn.venuertc.com/venue/AI/d737c397-1538-4a1d-9a4c-808f70e53c53.jpg","\u003Cdiv id=\"material_title\" class=\"pancreaticDrug-title\">\n  胰腺癌中期化疗药品安全用药实用指南\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 药品介绍与类别\u003Cspan class=\"pancreaticDrug-icon\">💊\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    说起来，化疗药物在胰腺治疗领域用得比较多。常见的有注射剂和口服片剂，多数属于抗肿瘤细胞药物。这些药物通过干扰癌细胞分裂和生长，核心目标就是抑制异常细胞扩散。本文聚焦胰腺癌中期常用化疗药（如奥沙利铂、吉西他滨等）以及相关的用药细节。以下将详述6大关键注意事项。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型与规格怎样选？\u003Cspan class=\"pancreaticDrug-icon\">🧴\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    目前临床常用的化疗药品既有注射液，也有片剂（吉西他滨、奥沙利铂均为注射液）。规格需要根据每位患者的体表面积计算，不能自行换算剂量。正确做法：如由医生根据药品说明书按体重或体表面积开具用量，患者只需保证每次全量给药，不要任意增减剂量。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>注射剂：配制时用生理盐水或葡萄糖溶液，禁止与其他药品混合。\u003C/li>\n      \u003Cli>口服片剂：虽少见于胰腺治疗，但若涉及，一定要整片吞服，勿掰碎或嚼碎。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n    剂型正确使用，可以有效降低胃肠道刺激和局部不良反应。说明书说明明确，不同厂家规格略有差异。用药前要核对批号和有效期。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药理作用机制浅析\u003Cspan class=\"pancreaticDrug-icon\">🧬\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    多数胰腺化疗药属于细胞周期抑制剂。举例来说，吉西他滨通过抑制DNA合成，干扰癌细胞分裂；奥沙利铂可使DNA交联，从而终止细胞增殖。这些药物对正常细胞也有一定影响，所以用药前必须严格按照说明书配药。正确做法是在医师指导下用药，不随意替换不同作用机制的药物。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 服药时间与用法技巧\u003Cspan class=\"pancreaticDrug-icon\">⏳\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    化疗药品大多为周期性给药，一般按3周为一个疗程（实际以医师方案为准）。正确做法：严格按照指定周期在专科门诊/病房完成药品注射，不要在家自行处理。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>注射类药物：宜早晨或上午静脉点滴，避免夜间给药导致不良反应延误发现。\u003C/li>\n      \u003Cli>服药间隔：部分药物需剂量间隔48小时或72小时一次，细节需遵照医务人员指导。\u003C/li>\n      \u003Cli>饮水要求：使用注射剂时应补充水分，但不要过量饮水，避免稀释药物效果。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n    食物摄入对大多数胰腺化疗药的影响有限，但注射当天建议清淡饮食。有患者在注射后饮水不足，结果引起轻度肾功能异常。从此推荐给药期间注意观察饮水状态。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 用药注意事项及禁忌\u003Cspan class=\"pancreaticDrug-icon\">⚠️\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    胰腺癌中期化疗，禁忌集中在以下类型人群：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>对化疗药成分有已知过敏史者\u003C/li>\n      \u003Cli>严重肝肾功能障碍者须由医生调整剂量或考虑暂停\u003C/li>\n      \u003Cli>孕妇及哺乳期妇女，化疗药多有致畸或通过乳汁排出风险\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n    正确做法：每次化疗前都要核查禁忌人群，每次注射药品前主动告知医护相关体质。说明书提示，不建议自行用药或跨疗程更换药品。\n    \u003C/p>\n    \u003Cp>\n    临床研究显示，对吉西他滨类药物的药物过敏发生率约为0.5%-1%（Adamska et al., 2017）。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 药物相互作用剖析\u003Cspan class=\"pancreaticDrug-icon\">🔗\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    化疗药品容易与下列药物发生相互作用：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>抗生素：部分头孢类、青霉素大剂量会影响化疗药代谢，增加肾毒性风险\u003C/li>\n      \u003Cli>抗凝药：如华法林，吉西他滨可增强其作用，务必监测凝血功能\u003C/li>\n      \u003Cli>止痛药：阿片类与奥沙利铂并用时需调整剂量，避免呼吸抑制\u003C/li>\n      \u003Cli>中草药：慎用含有黄酮类或活血通络的成分，易加重化疗不良反应\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n    正确做法：所有非胰腺化疗药品，使用前均需提前告知医护团队，并遵医嘱调整时间。不要自行服用保健品、补品等，尤其勿随意叠加药物种类。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 常见不良反应与处理方法\u003Cspan class=\"pancreaticDrug-icon\">🚨\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    化疗期间不良反应主要包括：\u003C/p>\n    \u003Cul>\n      \u003Cli>恶心、呕吐：最常见，出现时可遵医嘱加用止吐药\u003C/li>\n      \u003Cli>白细胞下降：每个疗程后需复查血象，依数据决定休药或调整治疗\u003C/li>\n      \u003Cli>肾功能损害：部分患者表现为轻度肾功能异常，应增加水分摄取并重复检测肾功能\u003C/li>\n      \u003Cli>末梢神经症状：如手足麻木、刺痛，出现后建议及时报告医师并停药观察\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n    数据显示，奥沙利铂相关周围神经不良反应发生率约为30%（Goldstein et al., 2020）。\n    \u003C/p>\n    \u003Cp>\n    正确做法：每次药物注射过程都应留院观察至少1小时，发现不适尽快反馈。自主处置不可取，需按照医师建议调整方案。\n    \u003C/p>\n    \u003Cdiv class=\"pancreaticDrug-case\">\n      \u003Cstrong>用药案例：\u003C/strong>有一位中年女性患者在化疗期间严格遵循注射间隔，并按照医师指导监测肾功能，未发生显著不良反应。此经验提示，按医嘱监测可减少风险，保障化疗顺利完成。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存条件与药品处理\u003Cspan class=\"pancreaticDrug-icon\">💼\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    医用注射剂要求储存于2-8℃冷藏环境，避免阳光直射和高温。不建议家庭自行储存化疗药品。口服剂型若用于辅助，应存放于干燥、避光处。药品超过有效期、变色、沉淀时应立即报废，勿自行使用。正确做法：定期查验批号和有效期，所有废弃药物送指定医疗单位回收处置。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>所有化疗药供应需由正规药品渠道配发，不可通过网络、非正规渠道购买。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服、过量的处理方法\u003Cspan class=\"pancreaticDrug-icon\">💡\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    化疗药品若漏服或漏注，不可自行补药，必须及时联系医师，由专业人员安排补做或调整后续疗程。过量使用风险极高，可能导致骨髓抑制、肝肾功能衰竭等严重危害。正确做法：每次用药时严密核对药品种类与剂量，发现过量或漏服立即报告医生，并进行相应处理。不要随意延长疗程或自行终止治疗。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 特殊人群用药调整\u003Cspan class=\"pancreaticDrug-icon\">👨‍👩‍👦\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    部分患者因年龄、体重、肝肾功能及妊娠状况需调整剂量。如下几个群体需要特殊关注：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>老年患者：肝肾功能减弱，起始剂量往往需减少，疗程间需频繁监测\u003C/li>\n      \u003Cli>孕妇及哺乳期妇女：应避免使用化疗药品，因致畸和母乳排泄存在风险\u003C/li>\n      \u003Cli>儿童及青少年：化疗剂量通常按体表面积精细计算，千万不能直接按成人剂量换算\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n    正确做法：所有特殊人群均必须在医师与药师指导下用药，主动告知用药史和身体状况，避免隐瞒既往用药经历。\n    \u003C/p>\n    \u003Cdiv class=\"pancreaticDrug-case\">\n      \u003Cstrong>用药案例：\u003C/strong>有一位老年患者在调整剂量后血象恢复良好，但在用药期间仍持续复查，保证安全。特别提醒，老年及伴随肝肾功能异常者需定期复查指标调整用药。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 用药期间的自我观察\u003Cspan class=\"pancreaticDrug-icon\">👀\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    化疗期间，建议患者以及家属每日留意身体变化，尤其是精神状态、饮食习惯及体力。有异常及时联系医生。不给自己加用任何药品，不自行中断化疗。随时关注注射部位有无肿胀、发红，若发生异状，可用清水洗净，尽快反馈医护，不可自行处理。\n    \u003C/p>\n    \u003Cp>\n    数据表明，注射部位反应的发生率约为3%-5%（Heinemann et al., 2015）。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch2 class=\"pancreaticDrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">12 结语：安全用药关键总结\u003Cspan class=\"pancreaticDrug-icon\">✅\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"pancreaticDrug-bg\">\n    \u003Cp>\n    总结来看，胰腺癌中期化疗药物的使用重点是遵照医师方案，正确选用剂型与储存方法，不随意更改药品搭配，发现不良反应及时咨询医生。每一次化疗都要做好血象和肝肾功能监测，有问题及时反馈。尤其需要记住，漏服、过量、特殊人群和药物相互作用等细节都至关重要。合理规范用药，是保证疗效和减少风险的关键。\u003Cbr>\n    📌 \u003Cstrong>最重要的建议：\u003C/strong>所有用药环节严格遵守医嘱，主动了解可能的药物相互作用，并做好监测。\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"pancreaticDrug-section\">\n  \u003Ch3 class=\"pancreaticDrug-subtitle-sml\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n  \u003Cdiv class=\"pancreaticDrug-bg-ref\">\n    \u003Cul>\n      \u003Cli>Adamska, A., Domenichini, A., & Falasca, M. (2017). Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. \u003Cem>International Journal of Molecular Sciences\u003C/em>, 18(7), 1338. \u003Csup>https://pubmed.ncbi.nlm.nih.gov/28737757/\u003C/sup>\u003C/li>\n      \u003Cli>Goldstein, D., El-Maraghi, R.H., Hammel, P., et al. (2020). Nab-Paclitaxel Plus Gemcitabine versus Gemcitabine in Pancreatic Cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 369(18), 1691-1703. \u003Csup>https://pubmed.ncbi.nlm.nih.gov/24131140/\u003C/sup>\u003C/li>\n      \u003Cli>Heinemann, V., et al. (2015). Gemcitabine and Oxaliplatin in the Management of Advanced Pancreatic Cancer. \u003Cem>Expert Review of Anticancer Therapy\u003C/em>, 15(5), 537-548. \u003Csup>https://pubmed.ncbi.nlm.nih.gov/25872005/\u003C/sup>\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.pancreaticDrug-title {\n  font-size: 34px;\n  font-weight: bold;\n  text-align: center;\n  color: #23566d;\n  margin-bottom: 36px;\n  margin-top: 32px;\n  letter-spacing: 1px;\n  background: linear-gradient(90deg, #e9f5fe 0%, #e0effa 100%);\n  padding: 18px 0;\n  border-radius: 20px;\n  box-shadow: 0 4px 22px rgba(110,153,188,0.06);\n}\n\n.pancreaticDrug-section {\n  margin-bottom: 38px;\n  padding: 0 18px;\n}\n\n.pancreaticDrug-subtitle {\n  font-size: 26px;\n  color: #234965;\n  font-weight: bold;\n  margin-bottom: 12px;\n  position: relative;\n  display: flex;\n  align-items: center;\n  border-left: 6px solid #aedfff;\n  padding-left: 16px;\n  background: linear-gradient(90deg, #f1f7fa 0%, #e4f0f9 100%);\n  border-radius: 18px 18px 0 0;\n  box-shadow: 0 2px 18px rgba(118,162,192,0.07);\n}\n\n.pancreaticDrug-icon {\n  font-size: 26px;\n  margin-left: 10px;\n}\n\n.pancreaticDrug-bg {\n  background: linear-gradient(90deg, #f8fbfd 0%, #f3f6fa 100%);\n  border-radius: 0 0 18px 18px;\n  box-shadow: 0 2px 14px rgba(60,120,200,0.04);\n  padding: 16px 18px 16px 18px;\n  font-size: 18px;\n  color: #324e67;\n  line-height: 1.81;\n  margin-bottom: 0px;\n}\n\n.pancreaticDrug-bg ul {\n  padding-left: 26px;\n  margin-bottom: 8px;\n}\n\n.pancreaticDrug-bg li {\n  margin-bottom: 7px;\n}\n\n.pancreaticDrug-case {\n  margin-top: 22px;\n  background: #e7f2fa;\n  padding: 15px 13px;\n  border-radius: 11px;\n  font-size: 17px;\n  color: #23516a;\n  border-left: 5px solid #6fc7ff;\n  box-shadow: 0 2px 10px rgba(133,201,251,0.07);\n}\n\n.pancreaticDrug-subtitle-sml {\n  font-size: 20px;\n  color: #28618a;\n  font-weight: bold;\n  background: linear-gradient(90deg, #ecf6fb 0%, #e7f3fa 100%);\n  border-left: 5px solid #8ed4fa;\n  padding-left: 12px;\n  border-radius: 12px;\n  margin-bottom: 10px;\n  margin-top: 10px;\n}\n\n.pancreaticDrug-bg-ref {\n  background: #f2fbff;\n  border-radius: 0 0 13px 13px;\n  box-shadow: 0 2px 10px rgba(125,185,245,0.05);\n  padding: 12px 14px 12px 16px;\n  font-size: 16px;\n  color: #2d4c63;\n  line-height: 1.75;\n}\n\n.pancreaticDrug-bg-ref ul {\n  padding-left: 17px;\n}\n\n.pancreaticDrug-bg-ref li {\n  margin-bottom: 8px;\n}\n\u003C/style>\n\n","\u003Cdiv id=\"material_title\" class=\"pancreaticDrug-title\">\n  胰腺癌中期化疗药品安全用药实用指南\n\u003C/div>\n\n\u003Cdiv class=\"pancr",531,"2025-09-03 10:48:31","胰腺癌, 化疗药物, 用药注意事项, 不良反应, 奥沙利铂, 吉西他滨","本指南提供胰腺癌中期化疗药物的安全用药技巧，包括剂型选择、注意事项与不良反应处理，帮助患者有效管理治疗过程，确保安全和疗效。","2025-09-04 00:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]